NO20035160L - Anvendelse av IL-18 inhibitorer til å behandle eller forhindre CNS-skader - Google Patents
Anvendelse av IL-18 inhibitorer til å behandle eller forhindre CNS-skaderInfo
- Publication number
- NO20035160L NO20035160L NO20035160A NO20035160A NO20035160L NO 20035160 L NO20035160 L NO 20035160L NO 20035160 A NO20035160 A NO 20035160A NO 20035160 A NO20035160 A NO 20035160A NO 20035160 L NO20035160 L NO 20035160L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- treat
- cns damage
- prevent cns
- prevent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01112067 | 2001-05-25 | ||
| PCT/EP2002/005666 WO2002096456A1 (en) | 2001-05-25 | 2002-05-23 | Use of il-18 inhibitors for treating or preventing cns injuries |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20035160D0 NO20035160D0 (no) | 2003-11-20 |
| NO20035160L true NO20035160L (no) | 2003-11-20 |
| NO331882B1 NO331882B1 (no) | 2012-04-23 |
Family
ID=8177454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20035160A NO331882B1 (no) | 2001-05-25 | 2003-11-20 | Anvendelse av IL-18 inhibitorer til a behandle eller forhindre CNS-skader |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7655616B2 (no) |
| EP (1) | EP1390070B1 (no) |
| JP (1) | JP4344142B2 (no) |
| KR (1) | KR20040030625A (no) |
| CN (1) | CN1305529C (no) |
| AU (1) | AU2002314103B2 (no) |
| BG (1) | BG66395B1 (no) |
| BR (1) | BR0210007A (no) |
| CA (1) | CA2445664C (no) |
| CY (1) | CY1119190T1 (no) |
| CZ (1) | CZ307321B6 (no) |
| DK (1) | DK1390070T3 (no) |
| EA (1) | EA006744B1 (no) |
| EE (1) | EE05263B1 (no) |
| ES (1) | ES2617084T3 (no) |
| HK (1) | HK1069762A1 (no) |
| HR (1) | HRP20030842B1 (no) |
| HU (1) | HU230294B1 (no) |
| IL (2) | IL159014A0 (no) |
| LT (1) | LT1390070T (no) |
| ME (1) | ME00550B (no) |
| MX (1) | MXPA03010743A (no) |
| NO (1) | NO331882B1 (no) |
| PL (1) | PL216228B1 (no) |
| PT (1) | PT1390070T (no) |
| RS (1) | RS56006B1 (no) |
| SK (1) | SK288413B6 (no) |
| UA (1) | UA80396C2 (no) |
| WO (1) | WO2002096456A1 (no) |
| ZA (1) | ZA200308172B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1622939T1 (sl) | 2003-05-13 | 2012-06-29 | Merck Serono Sa | Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega |
| NZ552908A (en) * | 2004-06-30 | 2009-11-27 | Atsuo Sekiyama | Indicator agent for noninflammatory stress response and use thereof |
| US8128920B2 (en) * | 2005-06-03 | 2012-03-06 | Merck Serono Sa | Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases |
| WO2006128908A1 (en) | 2005-06-03 | 2006-12-07 | Ares Trading S.A. | Production of recombinant il-18 binding protein |
| EP1891088B1 (en) | 2005-06-10 | 2011-10-19 | Ares Trading S.A. | Process for the purification of il-18 binding protein |
| US8685400B2 (en) | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| JP6820743B2 (ja) * | 2013-09-05 | 2021-01-27 | エイビー２ バイオ ソシエテアノニム | 炎症性疾患におけるｉｌ−１８結合タンパク質（ｉｌ−１８ｂｐ） |
| KR102511343B1 (ko) * | 2015-03-05 | 2023-03-17 | 에이비2 바이오 에스에이 | 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ) 및 항체 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0873453A (ja) * | 1994-09-02 | 1996-03-19 | Otsuka Pharmaceut Co Ltd | サイトカイン阻害剤 |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| DE69925581T2 (de) * | 1998-03-09 | 2006-04-27 | Vertex Pharmaceuticals Inc., Cambridge | 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| ME00554B (me) * | 2000-05-05 | 2012-03-20 | Serono Lab | KORIŠĆENJE IL-18 INHIBITORA ZA LIJEČENJE l/ILI PREVENCIJU ATEROSKLEROZE |
| EP1292288B1 (en) * | 2000-06-23 | 2004-09-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| WO2002032374A2 (en) * | 2000-10-18 | 2002-04-25 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| US6671553B1 (en) * | 2001-05-23 | 2003-12-30 | Pacesetter, Inc. | Implantable cardiac lead having terminating connector strain relief and method of manufacture |
-
2002
- 2002-05-23 PT PT2740641T patent/PT1390070T/pt unknown
- 2002-05-23 EA EA200301299A patent/EA006744B1/ru not_active IP Right Cessation
- 2002-05-23 SK SK1603-2003A patent/SK288413B6/sk not_active IP Right Cessation
- 2002-05-23 US US10/478,614 patent/US7655616B2/en not_active Expired - Lifetime
- 2002-05-23 IL IL15901402A patent/IL159014A0/xx unknown
- 2002-05-23 EP EP02740641.2A patent/EP1390070B1/en not_active Expired - Lifetime
- 2002-05-23 JP JP2002592965A patent/JP4344142B2/ja not_active Expired - Lifetime
- 2002-05-23 HU HU0304067A patent/HU230294B1/hu unknown
- 2002-05-23 CN CNB028147510A patent/CN1305529C/zh not_active Expired - Lifetime
- 2002-05-23 WO PCT/EP2002/005666 patent/WO2002096456A1/en active IP Right Grant
- 2002-05-23 LT LTEP02740641.2T patent/LT1390070T/lt unknown
- 2002-05-23 PL PL367545A patent/PL216228B1/pl unknown
- 2002-05-23 RS YU89403A patent/RS56006B1/sr unknown
- 2002-05-23 CA CA2445664A patent/CA2445664C/en not_active Expired - Lifetime
- 2002-05-23 KR KR10-2003-7015310A patent/KR20040030625A/ko active Search and Examination
- 2002-05-23 MX MXPA03010743A patent/MXPA03010743A/es active IP Right Grant
- 2002-05-23 BR BR0210007-0A patent/BR0210007A/pt not_active Application Discontinuation
- 2002-05-23 DK DK02740641.2T patent/DK1390070T3/en active
- 2002-05-23 AU AU2002314103A patent/AU2002314103B2/en not_active Expired
- 2002-05-23 ME MEP-2008-618A patent/ME00550B/me unknown
- 2002-05-23 ES ES02740641.2T patent/ES2617084T3/es not_active Expired - Lifetime
- 2002-05-23 EE EEP200300582A patent/EE05263B1/xx unknown
- 2002-05-23 UA UA20031212328A patent/UA80396C2/uk unknown
- 2002-05-23 CZ CZ2003-3268A patent/CZ307321B6/cs not_active IP Right Cessation
-
2003
- 2003-10-17 HR HRP20030842AA patent/HRP20030842B1/hr not_active IP Right Cessation
- 2003-10-21 ZA ZA200308172A patent/ZA200308172B/xx unknown
- 2003-11-20 NO NO20035160A patent/NO331882B1/no not_active IP Right Cessation
- 2003-11-23 IL IL159014A patent/IL159014A/en active IP Right Grant
- 2003-12-15 BG BG108451A patent/BG66395B1/bg unknown
-
2004
- 2004-12-31 HK HK04110391A patent/HK1069762A1/xx not_active IP Right Cessation
-
2017
- 2017-05-08 CY CY20171100494T patent/CY1119190T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054369D0 (no) | Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse | |
| DE60211317D1 (de) | Rho-kinase inhibitoren | |
| DE60218138D1 (de) | Rho-kinase inhibitoren | |
| NO20042080L (no) | Inhibitorer for post-prolin spaltningsproteaser | |
| DE60127098D1 (de) | Inhibitoren der mucin-synthese | |
| NO20026283L (no) | Inhibitorer av kobberholdige aminosydaser | |
| EE200300361A (et) | PDE4 isosüümide inhibiitoritena kasutatavad eetriderivaadid | |
| ATE333454T1 (de) | Metalloproteinaseinhibitoren | |
| EE200300439A (et) | Metalloproteinaasi inhibiitorid | |
| DK1485127T3 (da) | Anvendelse af midler til behandling af inflammation | |
| IS7792A (is) | Hýdantóínafleiður og notkun þeirra sem TACE hemla | |
| NO20050636L (no) | Inhibitorer av tyrosinkinaser | |
| NO20025307L (no) | Anvendelse av IL-18 inhibitorer til behandling og/eller forebygging av aterosklerose | |
| EE200300450A (et) | Metalloproteinaasi inhibiitorid | |
| NO20020742D0 (no) | Innskrenkning av innretninger for å lyddempe operasjoner | |
| NO20042244L (no) | Fenylsubstituerte triazoler og deres anvendelse som selektive inhibitorer av AKL5-kinease | |
| NO20054837D0 (no) | Formulering for inhibering av korrosjon og avleiringer | |
| NO20041214L (no) | Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer | |
| NO20035160D0 (no) | Anvendelse av IL-18 inhibitorer til å behandle eller forhindre CNS-skader | |
| NO20041938L (no) | Anvendelse av fosfodiesterase IV-inhibitorer | |
| EE200300512A (et) | Aromataasi inhibiitori kasutamine abistava reproduktsiooni suurendamiseks | |
| NO20033125D0 (no) | Anvendelse av antigestagener til inhibering av endometriummodning under infertilitetsbehandling | |
| IL160230A0 (en) | Use of il-18 inhibitors | |
| DE60229398D1 (de) | Behandlung der lipodystrophie mit renin-angiotensin system inhibitoren | |
| AU2003253346A1 (en) | Use or arylsulfonamido-substituted hydroxamid acid matrix metalloproteinase inhibitors for the treatment or prevention of toxemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |